Vaccine Information Statements
VISs by language
French-language VISs
Up-to-date
You are encouraged to distribute the up-to-date English-language VIS at the same time as the translation.
Hib VIS | English-language [12/16/98]
Polio - IPV VIS | English-language [1/01/00]
Polio - OPV VIS | English-language [1/01/00]
Oral polio vaccine is no longer available for use in the United States. These VISs are available on our website for the convenience of people outside the United States who choose to use them.
French-language VISs
Out-of-date
The translations for some VISs on our website are from previously published English-language versions that have since been updated. Unfortunately, IAC is not always able to obtain translations as updates are issued. Please ensure that your patients receive information consistent with the current English-language version of the following VISs.
You are encouraged to distribute the up-to-date English-language VIS at the same time as the translation.
MMR VIS | Up-to-date English-language [3/13/08]
These translations do not contain the following CDC updates:
  • Information was added about MMRV vaccine, tied to the March 14 MMWR, regarding increased risk of certain adverse events, including febrile seizures, with MMRV when compared with MMR and varicella vaccines given separately. Aside from two boxes containing information about MMRV, both VISs are identical to the previous editions.
  • The new VISs should be used when MMRV is given; but the existing stocks of the individual MMR and varicella VISs may be used when the vaccines are given separately.
Chickenpox VIS [12/16/98] | Up-to-date English-language [3/13/08]
This translation does not contain the following CDC updates:
  • Section 1: The answer has been rewritten by CDC.
  • Section 2: There are now 2 doses; the first dose is 12-15 months and the second dose is 4-6 years.
  • CDC added information on MMRV.
  • The URL for Vaccine Adverse Event Reporting System (VAERS) has changed.
  • The URL for the National Vaccine Injury Compensation Programs has changed.
DTaP VIS [8/15/97] | Up-to-date English-language [7/30/01]
This translation does not contain the following CDC updates:
  • Most of the changes to this VIS relate to the current exclusive use of the acellular DTaP; the previous VIS included the whole-cell DTP, which is no longer used in the U.S.
  • Rates of reactions (problems) that might be expected following DtaP have been changed and are generally lower that those following DTP.
  • The new URL for the National Injury Compensation Program is listed.
Hepatitis A VIS [8/25/98] | Up-to-date English-language [3/21/06]
This translation does not contain the following CDC updates:
  • CDC changed the indication to 1 year or older and has recommended routine use for children.
  • Section 2: Added persons who work with primates or in research labs to indications (routine vaccination).
  • Added bullet for "persons who live in communities that have prolonged outbreaks of hepatitis A."
  • Divided the section into "Who" and "When" parts.
  • Removed southern Europe from list of regions with high rates of hepatitis A.
  • Section 3: Added bullet about allergy to vaccine component.
  • Changed wording, particularly the statement on pregnancy, and made list into bullets.
  • Minor changes to part 4, 5, and 6 to be consistent with other recent VISs.
  • Removed the section on immune globulin.
Hepatitis B VIS [12/16/98] | Up-to-date English-language [7/18/07]
This translation does not contain the following CDC updates:
  • The number of new infections occurring annually is listed as 80,000 (previously 200,000).
  • "Sharing of needles" when injecting illegal drugs has been added as a way of spreading the virus.
  • The targeted groups to be vaccinated has been expanded to include public safety workers who might be exposed to infected blood or body fluids, household contacts of persons with chronic HBV infection, and hemodialysis patients.
  • A time frame "in 6 months" has been added to the risk factor "people who have more than one sex partner."
  • Information about the two-dose adolescent vaccine series has been added.
  • The statement "Serious allergic reactions are extremely rare with any vaccine" has been added.
  • The website of Vaccine Adverse Event Reporting System has been added.
  • A new URL for the National Vaccine Injury Compensation Program is listed.
Influenza - Inactivated VIS [5/24/04] | Up-to-date English-language [6/30/06]
This translation does not contain the following CDC updates:
  • CDC added recommending vaccination of children aged 24-59 months and their contacts.
  • Section 3: CDC added to the list of people at high risk for complications from influenza, "People with certain muscle or nerve disorders (such as seizure disorders or severe cerebral palsy) that can lead to breathing or swallowing disorders."
This translation does not contain the following CDC updates:
  • Female patients are now advised to postpone pregnancy for 4 weeks after receiving MMR vaccine (version 12/16/98 read "3 months").
  • The website of the Vaccine Adverse Event Reporting System has been added.
  • A new URL for the National Vaccine Injury Compensation Program has been added.
Thanks to the Minnesota Department of Health and the American Embassy Tunis - Medical Unit for their translations.

This page was updated on March 13, 2008

Immunization Action Coalition  |  1573 Selby Avenue  |  St. Paul MN 55104
contact: admin@immunize.org  |  www.immunize.org
tel: 651.647.9009  |  fax: 651.647.9131